The technical core of this, of course, was Wu Ting himself and Chief Engineer Liang Kangjun of Weixing Petrochemical Group!
The entire project kicked off and was soon in full swing!
Wu Ting personally wrote the core algorithm for the controllable, self-regulating delivery system. President Liang personally led a team to begin research and development on a brand-new material for the self-expanding airbag.
At the same time the new project was starting, good news also came from Jia Jun's side. Fengmu Tiada had already completed its preclinical studies. All that was needed was for Wu Ting to get approval for the relevant clinical trials, and it could officially enter the clinical trial phase!
The Hepatic Tumor Surgery department at City First Hospital would begin the first batch of clinical trials for Fengmu Tiada, and Zhang Heng's team would also officially begin their research.
